Stocktoria
Climb Bio, Inc. CLYM
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-08-10
Climb Bio, Inc. statistics & valuation
Market cap$749.0M
P / B4.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -35.7% | -34.0% | -31.8% | -33.5% | -27.4% |
| Return on equity | -37.3% | -34.9% | -32.6% | -35.2% | -28.4% |
| Current ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 |
Source: SEC EDGAR filings · CIK 0001768446 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.